Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus

ABSTRACT Objective: To evaluate the prevalence of osteosarcopenia and the association of osteosarcopenia with trabecular bone score (TBS) in a group of patients with type 2 diabetes mellitus(T2DMG) compared with a paired control group (CG). Materials and methods: Cross-sectional study with men and...

Full description

Bibliographic Details
Main Authors: Luciana Muniz Pechmann, Ricardo R. Petterle, Carolina A. Moreira, Victoria Z. C. Borba
Format: Article
Language:English
Published: Brazilian Society of Endocrinology and Metabolism 2021-11-01
Series:Archives of Endocrinology and Metabolism
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000600801&tlng=en
_version_ 1818972668455550976
author Luciana Muniz Pechmann
Ricardo R. Petterle
Carolina A. Moreira
Victoria Z. C. Borba
author_facet Luciana Muniz Pechmann
Ricardo R. Petterle
Carolina A. Moreira
Victoria Z. C. Borba
author_sort Luciana Muniz Pechmann
collection DOAJ
description ABSTRACT Objective: To evaluate the prevalence of osteosarcopenia and the association of osteosarcopenia with trabecular bone score (TBS) in a group of patients with type 2 diabetes mellitus(T2DMG) compared with a paired control group (CG). Materials and methods: Cross-sectional study with men and women ≥ 50 years recruited by convenience. Patients in both groups answered questionnaires and underwent evaluation of bone mineral density (BMD), handgrip strength (HGS), and TBS. The T2DMG also underwent a gait speed (GS) test. Sarcopenia was defined as low lean mass plus low HGS or GS according to the Foundation for the National Institute of Health Sarcopenia Project, and osteosarcopenia was deemed present when sarcopenia was associated with osteopenia, osteoporosis, or low-energy trauma fractures. Results: The T2DMG (n = 177) and CG (n = 146) had, respectively, mean ages of 65.1 ± 8.2 years and 68.8 ± 11.0 years and 114 (64.4%) and 80 (54.7%) women. T2DMG versus the CG had higher rates of osteosarcopenia (11.9% versus 2.14%, respectively, p = 0.010), sarcopenia (12.9% versus 5.4%, respectively, p < 0.030), and fractures (29.9% versus 18.5%, respectively, p = 0.019), and lower HGS values (24.4 ± 10.3 kg versus 30.9 ± 9.15 kg, respectively, p < 0.001), but comparable BMD values. Mean TBS values were 1.272 ± 0.11 and 1.320 ± 0.12, respectively (p = 0.001). On multivariate analysis, age, greater waist circumference, fractures, and osteoporosis increased the risk of degraded TBS. Osteosarcopenia was associated with diabetes complications (p = 0.03), calcium and vitamin D supplementation (p = 0.01), and all components of osteosarcopenia diagnosis (p < 0.05). Conclusion: Compared with the CG, the T2DMG had a higher prevalence of osteosarcopenia, sarcopenia, and fractures and lower bone quality assessed by TBS.
first_indexed 2024-12-20T15:11:56Z
format Article
id doaj.art-9b2bbc694eab46d39edbfb581f78a8a0
institution Directory Open Access Journal
issn 2359-4292
language English
last_indexed 2024-12-20T15:11:56Z
publishDate 2021-11-01
publisher Brazilian Society of Endocrinology and Metabolism
record_format Article
series Archives of Endocrinology and Metabolism
spelling doaj.art-9b2bbc694eab46d39edbfb581f78a8a02022-12-21T19:36:17ZengBrazilian Society of Endocrinology and MetabolismArchives of Endocrinology and Metabolism2359-42922021-11-0165680181010.20945/2359-3997000000418Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitusLuciana Muniz Pechmannhttps://orcid.org/0000-0002-2965-5268Ricardo R. Petterlehttps://orcid.org/0000-0001-7735-1077Carolina A. Moreirahttps://orcid.org/0000-0002-9908-4907Victoria Z. C. Borbahttps://orcid.org/0000-0003-0555-0880ABSTRACT Objective: To evaluate the prevalence of osteosarcopenia and the association of osteosarcopenia with trabecular bone score (TBS) in a group of patients with type 2 diabetes mellitus(T2DMG) compared with a paired control group (CG). Materials and methods: Cross-sectional study with men and women ≥ 50 years recruited by convenience. Patients in both groups answered questionnaires and underwent evaluation of bone mineral density (BMD), handgrip strength (HGS), and TBS. The T2DMG also underwent a gait speed (GS) test. Sarcopenia was defined as low lean mass plus low HGS or GS according to the Foundation for the National Institute of Health Sarcopenia Project, and osteosarcopenia was deemed present when sarcopenia was associated with osteopenia, osteoporosis, or low-energy trauma fractures. Results: The T2DMG (n = 177) and CG (n = 146) had, respectively, mean ages of 65.1 ± 8.2 years and 68.8 ± 11.0 years and 114 (64.4%) and 80 (54.7%) women. T2DMG versus the CG had higher rates of osteosarcopenia (11.9% versus 2.14%, respectively, p = 0.010), sarcopenia (12.9% versus 5.4%, respectively, p < 0.030), and fractures (29.9% versus 18.5%, respectively, p = 0.019), and lower HGS values (24.4 ± 10.3 kg versus 30.9 ± 9.15 kg, respectively, p < 0.001), but comparable BMD values. Mean TBS values were 1.272 ± 0.11 and 1.320 ± 0.12, respectively (p = 0.001). On multivariate analysis, age, greater waist circumference, fractures, and osteoporosis increased the risk of degraded TBS. Osteosarcopenia was associated with diabetes complications (p = 0.03), calcium and vitamin D supplementation (p = 0.01), and all components of osteosarcopenia diagnosis (p < 0.05). Conclusion: Compared with the CG, the T2DMG had a higher prevalence of osteosarcopenia, sarcopenia, and fractures and lower bone quality assessed by TBS.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000600801&tlng=enSarcopeniatype 2 diabetes mellitusmuscle weaknessfracturesosteoporosis
spellingShingle Luciana Muniz Pechmann
Ricardo R. Petterle
Carolina A. Moreira
Victoria Z. C. Borba
Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus
Archives of Endocrinology and Metabolism
Sarcopenia
type 2 diabetes mellitus
muscle weakness
fractures
osteoporosis
title Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus
title_full Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus
title_fullStr Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus
title_full_unstemmed Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus
title_short Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus
title_sort osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus
topic Sarcopenia
type 2 diabetes mellitus
muscle weakness
fractures
osteoporosis
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000600801&tlng=en
work_keys_str_mv AT lucianamunizpechmann osteosarcopeniaandtrabecularbonescoreinpatientswithtype2diabetesmellitus
AT ricardorpetterle osteosarcopeniaandtrabecularbonescoreinpatientswithtype2diabetesmellitus
AT carolinaamoreira osteosarcopeniaandtrabecularbonescoreinpatientswithtype2diabetesmellitus
AT victoriazcborba osteosarcopeniaandtrabecularbonescoreinpatientswithtype2diabetesmellitus